Minireview: Hexose-6-Phosphate Dehydrogenase and Redox Control of 11β-Hydroxysteroid Dehydrogenase Type 1 Activity
The DOI matches its Crossref record; 42 of the 43 references it cites were found in a registry or an index.
Abstract
Hexose-6-phosphate dehydrogenase (H6PDH) is a microsomal enzyme that is able to catalyze the first two reactions of an endoluminal pentose phosphate pathway, thereby generating reduced nicotinamide adenine dinucleotide phosphate (NADPH) within the endoplasmic reticulum. It is distinct from the cytosolic enzyme, glucose-6-phosphate dehydrogenase (G6PDH), using a separate pool of NAD(P)+ and capable of oxidizing several phosphorylated hexoses. It has been proposed to be a NADPH regenerating system for steroid hormone and drug metabolism, specifically in determining the set point of 11β-hydroxysteroid dehydrogenase type 1 (11β-HSD1) activity, the enzyme responsible for the activation and inactivation of glucocorticoids. 11β-HSD1 is a bidirectional enzyme, but in intact cells displays predominately oxo-reductase activity, a reaction requiring NADPH and leading to activation of glucocorticoids. However, in cellular homogenates or in purified preparations, 11β-HSD1 is exclusively a dehydrogenase. Because H6PDH and 11β-HSD1 are coexpressed in the inner microsomal compartment of cells, we hypothesized that H6PDH may provide 11β-HSD1 with NADPH, thus promoting oxo-reductase activity in vivo. Recently, several studies have confirmed this functional cooperation, indicating the importance of intracellular redox mechanisms for the prereceptor control of glucocorticoid availability. With the increased interest in 11β-HSD1 oxo-reductase activity in the pathogenesis and treatment of several human diseases including insulin resistance and the metabolic syndrome, H6PDH represents an additional novel candidate for intervention.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Citations
Cites
Cloning and tissue distribution of the human 1 lβ-hydroxysteroid dehydrogenase type 2 enzyme
Albiston, A. L., Obeyesekere, V. R., Smith, R. E., & Krozowski, Z. S. (1994) · Molecular and Cellular Endocrinology · doi:10.1016/0303-7207(94)90176-7 · Cited by 712 · cited 1×
“activate the mineralocorticoid receptor in vivo (22, 23).”
BackgroundTissue-Specific Dysregulation of Cortisol Metabolism in Human Obesity
Rask, E. (2001) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.86.3.1418 · Cited by 655 · cited 1×
“They should also raise increased awareness of the pitfalls of measuring only 11 -dehydrogenase activity in vitro and inferring from this that this is representative of 11-oxo-reductase activity in vivo (42).”
BackgroundLAKSHMI, V., & MONDER, C. (1988) · Endocrinology · doi:10.1210/endo-123-5-2390 · Cited by 311
HAUNER, H., SCHMID, P., & PFEIFFER, E. F. (1987) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-64-4-832 · Cited by 308 · cited 1×
“tissue; here its oxo-reductase activity has been implicated in the pathogenesis of the metabolic syndrome through increased local generation of cortisol facilitating hepatic glucose output (28) and adipocyte differentiation (29).”
BackgroundJamieson, P. M., Chapman, K. E., Edwards, C. R. W., & Seckl, J. R. (1995) · Endocrinology · doi:10.1210/en.136.11.4754 · Cited by 301
Type I Glycogen Storage Diseases: Disorders of the Glucose-6- Phosphatase Complex
Chou, J., Matern, D., Mansfield, B., & Chen, Y.-T. (2002) · Current Molecular Medicine · doi:10.2174/1566524024605798 · Cited by 298 · cited 1×
“Supply of G6P is ensured by the glucose-6-phosphate transporter of the ER, which is specific for G6P (7).”
BackgroundDraper, N., Walker, E. A., Bujalska, I. J., Tomlinson, J. W., Chalder, S. M., Arlt, W., Lavery, G. G., Bedendo, O., Ray, D. W., Laing, I., et al. (2003) · Nature Genetics · doi:10.1038/ng1214 · Cited by 285 · cited 1×
“candidates are likely to be involved (38).”
Self-citationAlberts, P., Nilsson, C., Selén, G., Engblom, L. O. M., Edling, N. H. M., Norling, S., Klingström, G., Larsson, C., Forsgren, M., Ashkzari, M., et al. (2003) · Endocrinology · doi:10.1210/en.2003-0344 · Cited by 263 · cited 1×
“Inhibition of 11 -HSD1, using selective inhibitors, has resulted in improved insulin sensitivity and weight loss (30, 31), but the factors determining 11 -HSD1 set point and oxo-reductase activity per se have remained elusive.”
BackgroundBujalska, I. J., Kumar, S., Hewison, M., & Stewart, P. M. (1999) · Endocrinology · doi:10.1210/endo.140.7.6868 · Cited by 254 · cited 1×
“(33), where differences in oxoreductase-dehydrogenase activities of 11 -HSD1 in human omental and sc adipose stromal cells could not be explained by differences in G6PDH activity.”
BackgroundSelf-citationGlucocorticoids and 11beta-Hydroxysteroid Dehydrogenase in Adipose Tissue
Seckl, J. R. (2004) · Recent Progress in Hormone Research · doi:10.1210/rp.59.1.359 · Cited by 239 · cited 1×
“Additionally, neuronal cells have also been shown to have bidirectional activity (37).”
Background
Cited by
Items 101–153 of 153
Han, L., Wang, S., Zheng, J., Zhu, Y., Wang, Y., Li, H., & Ge, R. (2023) · Ecotoxicology and Environmental Safety · doi:10.1016/j.ecoenv.2023.115638 · Cited by 10
Ayari, H., Legedz, L., Lantelme, P., Feugier, P., Randon, J., Cerutti, C., Lohez, O. D., Scoazec, J., Li, J. Y., GHARBI-CHIHI, J., et al. (2012) · Fundamental and Clinical Pharmacology · doi:10.1111/j.1472-8206.2012.01064.x · Cited by 9
Gottfried‐Blackmore, A., Jellinck, P. H., Vecchiarelli, H. A., Masheeb, Z., Kaufmann, M., McEwen, B. S., & Bulloch, K. (2013) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2013.07.001 · Cited by 9
Bray, B., Scholl, J. L., Tu, W., Watt, M. J., Renner, K. J., & Forster, G. L. (2016) · Brain Research · doi:10.1016/j.brainres.2016.05.030 · Cited by 11
“…enzyme, hexose 6 phosphate de-hydrogenase (H6PD), directly interacts with 11β-HSD1 in central tissue to stabilize 11β-HSD1 reductase activity (White et al., 2007), regulating 11β-HSD1-imposed glucocorticoid activation in peripheral and central tissues (Hewitt et al., 2005; White et al., 2007).”
BackgroundWang, H., Sang, J., Ji, Z., Yu, Y., Wang, S., Zhu, Y., Li, H., Wang, Y., & Ge, R. (2024) · Environmental Toxicology · doi:10.1002/tox.24124 · Cited by 8
Kang, H. Y., Choi, Y.-K., Jeong, Y. I., Choi, K., Hyun, S., Hwang, W. S., & Jeung, E. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18122625 · Cited by 8
“11β-hydroxysteroid dehydrogenase type 1 (HSD11B1) is a nicotinamide adenine dinucleotide phosphate (NADPH)-dependent enzyme located within the lumen of the endoplasmic reticulum (ER) [2] that is highly expressed in metabolic tissue including that of the liver, adipose tissue, and the”
BackgroundInfluentialA missing enzyme-rescue metabolite as cause of a rare skeletal dysplasia
Jacobs, J., Lyubenova, H., Potelle, S., Kopp, J., Gerin, I., Chan, W. L., Santos, M. R. D. L., Hülsemann, W., Mensah, M. A., Cormier‐Daire, V., et al. (2025) · Nature · doi:10.1038/s41586-025-09397-x · Cited by 7
“3d) is known to maintain a very low NADP + /NADPH ratio in the endoplasmic reticulum to support the function of reductases 25,26 .”
Cell Death and Stress Signaling in Glycogen Storage Disease Type I
Kim, S. Y., & Bae, Y. S. (2009) · Molecules and Cells · doi:10.1007/s10059-009-0126-8 · Cited by 8
Wang, J., Wang, Y., Liu, L., Lutfy, K., Friedman, T. C., Liu, Y., Jiang, M., & Liu, Y. (2019) · Clinical Science · doi:10.1042/cs20190679 · Cited by 7
Zhu, Q., Dong, Y., Li, X., Ni, C., Huang, T., Sun, J., & Ge, R. (2020) · Frontiers in Endocrinology · doi:10.3389/fendo.2019.00886 · Cited by 8
Wang, H., Sang, J., Ji, Z., Yu, Y., Wang, S., Zhu, Y., Li, H., Wang, Y., Zhu, Q., & Ge, R. (2023) · Molecules · doi:10.3390/molecules28134894 · Cited by 10
“The reductive di ection of 11β-HSD1 is determined by the intraluminal microsomal hex se-6-phosphate dehydrogenase, which uses glucose-6-p osphate (G6 ) to generat NAD H, deriving 11β-HSD1 toward reductive catalysis [18].”
BackgroundMethodInfluentialRahman, T., Walker, E. A., Mayosi, B. M., Hall, D. H., Avery, P. J., Connell, J., Watkins, H. C., Stewart, P. M., & Keavney, B. D. (2011) · PLoS ONE · doi:10.1371/journal.pone.0023248 · Cited by 7
“NADPH generated by H6PDH is an essential cofactor for the action of 11b-HSD1 in reducing cortisone to cortisol, which takes place chiefly in the liver and adipose tissue [3].”
BackgroundSelf-citationLiu, L., Wang, Y., Wang, J., Dong, Y., Chang, S., Liu, X., Lutfy, K., Chen, H., Friedman, T. C., Jiang, M., et al. (2018) · International Journal of Obesity · doi:10.1038/s41366-018-0041-1 · Cited by 7
Metabolic Dysfunction in Idiopathic Intracranial Hypertension: Current Theories and Updates
Li, H., Liu, L., Zhou, Y., Jiang, H., Zhang, W., Zhou, C., Wu, C., Zhou, C. Y., & Ji, X. (2024) · Aging and Disease · doi:10.14336/ad.2024.1147 · Cited by 10
“Glucocorticoids represent a category of pleiotropic steroid hormones that exert extensive influences on systemic metabolism and are implicated in the pathophysiology of IIH [81] .”
Li, X., Hu, G., Li, X., Wang, Y., Hu, Y., Zhou, H.-Y., Latif, S. A., Morris, D. J., Chu, Y., Zheng, Z., et al. (2015) · PLoS ONE · doi:10.1371/journal.pone.0141767 · Cited by 7
Patronas, E., Balber, T., Miller, A., Geist, B. K., Michligk, A., Vraka, C., Krisch, M., Rohr‐Udilova, N., Haschemi, A., Viernstein, H., et al. (2023) · iScience · doi:10.1016/j.isci.2023.108137 · Cited by 5
“48 To further understand these effects, we separately knocked down both of the first oxPPP enzymes, G6PD and H6PD (Figure 7).”
BackgroundYaw, H. P., Ton, S. H., Kadir, K. A., Tan, T. Y., Teo, Y. W., & Yohanes, M. (2013) · The Open Bioactive Compounds Journal · doi:10.2174/1874847301004010014 · Cited by 5
“) generation of reduced adenine dinucleotide phosphate (NADPH) from NADP + [13,14].”
BackgroundBini, J., Strober, J. W., Kapinos, M., Zheng, M., Li, S., Ropchan, J. R., Nabulsi, N., Huang, Y. H., Perry, R. J., Vatner, D. F., et al. (2024) · Molecular Imaging · doi:10.1177/15353508241301584 · Cited by 4
Losartan in Marfan Syndrome—Beyond Blood Pressure Lowering
Habashi, J. P., Judge, D. P., Holm, T. M., Cohn, R. D., Loeys, B., Cooper, T. K., Myers, L. A., Klein, E. C., Liu, G., Calvi, C. L., et al. (2006) · Journal of the American Society of Nephrology · doi:10.1681/asn.2006050508 · Cited by 4
Cortisol Metabolism in Inflammation and Sepsis
Venkatesh, B., & Cohen, J. (2008) · Yearbook of intensive care and emergency medicine · doi:10.1007/978-3-540-77290-3_48 · Cited by 3
Chandrakesan, P., Sambandam, Y., Ilangovan, R., Janani, P., Palaniyandi, K., Balaganesh, M., Bhaskaran, N., Sittadjody, S., & Balasubramanian, K. (2009) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2009.06.014 · Cited by 3
Foster, C., Mick, G. J., Wang, X., & McCormick, K. L. (2013) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2013.05.001 · Cited by 3
Effect of diabetes on enzymes involved in rat hepatic corticosterone production
Hyatt, T. C., Chen, R., Wang, X., Mick, G. J., & McCormick, K. L. (2010) · Journal of Diabetes · doi:10.1111/j.1753-0407.2010.00087.x · Cited by 3
Physiologie et exploration des sécrétions de cortisol et d'androgènes par la surrénale
Oudet, B., Rigabert, J., Young, J., & Raffin‐Sanson, M. (2010) · EMC - Endocrinologie - Nutrition · doi:10.1016/s1155-1941(10)43047-4 · Cited by 8
Porzezińska-Furtak, J., Krzyżanowska‐Świniarska, B., Miazgowski, T., Ziemak, J., & Widecka, K. (2009) · Endokrynologia, Otyłość i Zaburzenia Przemiany Materii · Cited by 9
Ohno, S., Ohta, M., & Nakajin, S. (2010) · Hormone Molecular Biology and Clinical Investigation · doi:10.1515/hmbci.2010.020 · Cited by 2
“The G6P is transported via the G6P transporter (G6PT) within the ER lumen from cytosol w(3), original references are cited in this reviewx.”
BackgroundModulation of glucose and lipid metabolism in adrenalectomised rats given glycyrrhizic acid
Ng, Y. Y. E., Chandramouli, C., Ton, S. H., Kadir, K. A., Haque, F., & Tamotharan, M. (2012) · Journal of Molecular Pathophysiology · doi:10.5455/jmp.20120221113254 · Cited by 2
“It has a bifunctional activity where H6PDH oxidizes glucose-6phosphate (G6P) to 6-phosphogluconolactone (6PGL) and concomitantly generates reduced nicotinamide adenine dinucleotide phosphate (NADPH) from NADP + [10-11].”
BackgroundRedox status parameters and PBMC membrane fluidity in diabetes mellitus
Margina, D. M., Ilie, M., Grădinaru, D., Vladica, M., Pencea, C., Mitrea, N., & Katona, É. (2009) · Clinical and Experimental Medical Journal · doi:10.1556/cemed.3.2009.2.8 · Cited by 2
Tissue-Specific Functions of p53 During Kidney Development
Saifudeen, Z. R. (2017) · Results and problems in cell differentiation · doi:10.1007/978-3-319-51436-9_5 · Cited by 2
“4 Pentose phosphate pathway Catalyzes the first two reactions of the PPP, thus generating NADPH (Hewitt et al. 2005).”
BackgroundRat 3α-Hydroxysteroid Dehydrogenase: To Oxidize or Reduce, that Is the Question
Baker, M. E. (2006) · Endocrinology · doi:10.1210/en.2005-1664 · Cited by 2
Hao, T., Zhao, X., Ji, Z., Xia, M., Han, L., Sang, J., Wang, S., Li, L., Ge, R., & Zhu, Q. (2024) · Comparative Biochemistry and Physiology Part C Toxicology & Pharmacology · doi:10.1016/j.cbpc.2024.109900 · Cited by 1
Ritz, E. (2006) · Cited by 1
Yaw, H. P., Ton, S. H., Amanda, S., Kong, I. G. X. F., Cheng, H. S., Fernando, H. A., Chin, H.-F., & Kadir, K. A. (2014) · Monash University Research Portal (Monash University) · Cited by 2
Naseri, R., Alimoradi, Y., Sohrabi, M., Fard, M. C., Barzingarosi, E., Abdolmaleki, A., & Jalili, C. (2022) · PubMed Central · doi:10.22074/ijfs.2021.141690.1050 · Cited by 1
“D151A AA AC CC AC+CC 86 (86) 13 (13) 1 (1) 14 (14) 82 (82) 16 (16) 2 (2) 18(18) 0.”
BackgroundRedox Imbalance in the Endoplasmic Reticulum
Bánhegyi, G., Margittai, É., Csala, M., & Mandl, J. (2009) · Contemporary clinical neuroscience · doi:10.1007/978-1-60327-342-8_3 · Cited by 2
The Skinny on Fat: How Oxysterols May Regulate Functional Glucocorticoids in Adipose Tissue
Yudt, M. R., & Freedman, L. P. (2008) · Endocrinology · doi:10.1210/en.2008-1340 · Cited by 1
Bánhegyi, G., Benedetti, A., & Csala, M. (2008) · Wiley eBooks · doi:10.1002/9780470048672.wecb152 · Cited by 1
Estrogen and Glucocorticoid Metabolism
Andersson, T. (2010) · DiVA at Umeå University (Umeå University)
Plasma Cortisol: Time to Look Deeper?
Cohen, J., Prins, J. B., & Venkatesh, B. (2007) · Springer eBooks · doi:10.1007/978-0-387-49518-7_11
“Thus, concentrations of NADPH (which in turn are determined by cytosolic redox) influence the activity of the enzyme [39].”
BackgroundTitle of dissertation: HIGH SUCROSE, FRUCTOSE, AND GLUCOSE DIETS AND GLUCOCORTICOID DYSREGULATION IN
London, E., & Castonguay, T. W. (2009)
Characterising the phenotype and impact of adipose in idiopathic intracranial hypertension
Westgate, C. S. J. (2019) · University of Birmingham Institutional Research Archive (University of Birmingham)
Mechanisms and Effects Of Mineralocorticoid Receptor Signalling in Macrophages
Ong, S. Y. G. (2020) · Figshare · doi:10.26180/12254051
Nakamura, S., Yamashita, R., Miyauchi, Y., Tanaka, Y., & Ishii, Y. (2021) · Xenobiotica · doi:10.1080/00498254.2021.2001075
“NAD(P)þ-dependent dehydrogenases, such as 11b-hydroxysteroid dehydrogenase and hexose-6phosphate dehydrogenase, are present in the lumen of the ER (Hewitt et al. 2005).”
BackgroundCortisol Metabolism in Inflammation and Sepsis
Venkatesh, B., & Cohen, J. (2009) · Springer eBooks · doi:10.1007/978-0-387-77383-4_48
Plasma Cortisol: Time to Look Deeper?
Cohen, J., Prins, J. B., & Venkatesh, B. (2007) · Yearbook of intensive care and emergency medicine · doi:10.1007/978-3-540-49433-1_11 · Cited by 1
The Importance of PET Imaging to Understanding Whole-Body Cortisol Metabolism in Alzheimer’s Disease
Bini, J. (2024) · Journal of Alzheimer s Disease · doi:10.3233/jad-231463
“The regeneration of cortisol through 11 (cid:2) -HSD1 is driven by colocalization with hexose-6-phosphate dehydrogenase (H6PDH) in multiple tissues, such as brain, liver, and adipose [6].”
Regulation of intra-adipose cortisol concentrations in vivo in humans
Hughes, K. A. (2011) · OpenGrey (Institut de l'Information Scientifique et Technique)
Li, L., Chen, H., Zhu, Y., Ge, R., Chen, C., & Chen, S. (2026) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2026.117861
Zhao, C., Yu, Z., Wang, M., Ying, Y., Tang, Y., Li, H., Ge, R., & Liang, J. (2026) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2026.117883
Metabolite Damage and Repair in Health and Disease
Linster, C. L., Veiga‐da‐Cunha, M., Niehaus, T. D., Bommer, G. T., & SCHAFTINGEN, E. V. (2026) · Annual Review of Nutrition · doi:10.1146/annurev-nutr-062024-123639
Metadata
- Authors
- Hewitt, K. N., Walker, E. A., & Stewart, P. M.
- Affiliations
- University of Birmingham (GB)
- ORCID
- Stewart, Paul M.
- Venue
- Endocrinology
- Publisher
- The Endocrine Society
- Published
- 2005-06-01
- Volume
- 146
- Issue
- 6
- Pages
- 2539-2543
- ISSN
- 0013-7227 (ISSN-L)
- 1945-7170
- OpenAlex
- W2062256053
- Semantic Scholar
- f1688d0d0bec0ec882986aab5aa549e0384f021c
- Cited by
- 149
- References
- 43
- Citations by year
- 2026: 3 · 2025: 1 · 2024: 4 · 2023: 4 · 2022: 3 · 2021: 3 · 2020: 5 · 2019: 2 · 2018: 1 · 2017: 3 · 2016: 4 · 2015: 3 · 2014: 7 · 2013: 6 · 2012: 8
- FWCI
- 1.45
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Endocrinology (publishedVersion)
- PubMed (publishedVersion)
- University of Birmingham Research Portal (University of Birmingham) (submittedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Redox biology and oxidative stress
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hormonal Regulation and Hypertension
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
- Keywords
- hexose-6-phosphate dehydrogenase, 11β-hydroxysteroid dehydrogenase type 1, NADPH regeneration, redox regulation, pentose phosphate pathway, endoplasmic reticulum, microsomal enzymes, insulin resistance, metabolic syndrome, steroid hormone metabolism
- MeSH terms
- Animals, Carbohydrate Dehydrogenases, Energy Metabolism, Humans, Oxidation-Reduction, 11-beta-Hydroxysteroid Dehydrogenase Type 1
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.